I can't remember ever being this low
GLP-1 receptor agonists were originally developed to improve glycemic control
ER, endoplasmic reticulum, GLP-1, glucagon-like peptide 1, GLP-1 RAs, glucagon-like peptide 1 receptor agonists
Therefore, in patients where the fasting glucose is a more dominant feature of their hyperglycemia, metformin may be more appropriate, while GLP-1RAs could be better suited for those with postprandial hyperglycemia
The sensation of coldness appears more closely linked to the metabolic and physical changes accompanying weight reduction
Some individuals may feel a brief sting or discomfort at the injection site, while others may not feel anything at all